Mechanism-based candidate inhibitors of uridine diphosphate galactopyranose mutase (UGM)

被引:2
|
作者
Mahdavi-Amiri, Yasaman [1 ]
Mohan, Sankar [1 ]
Borrelli, Silvia [1 ]
Slowski, Kathryn [2 ]
Sanders, David A. R. [2 ]
Pinto, B. Mario [1 ]
机构
[1] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
[2] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Enzyme inhibitors; Mycobacterium tuberculosis; Synthesis; Transition-state analogues; UDP-galactopyranose mutase; UGM; STD-NMR SPECTROSCOPY; UDP-GALACTOPYRANOSE; GLUCOSIDASE INHIBITORS; STEREOSELECTIVE-SYNTHESIS; BIOLOGICAL EVALUATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; SUBSTRATE; BINDING; ANALOGS;
D O I
10.1016/j.carres.2015.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uridine diphosphate-galactopyranose mutase (UGM), an enzyme found in many eukaryotic and prokaryotic human pathogens, catalyzes the interconversion of UDP-galactopyranose (UDP-Galp) and UDP-galactofuranose (UDP-Galf), the latter being used as the biosynthetic precursor of the galactofuranose polymer portion of the mycobacterium cell wall. We report here the synthesis of a sulfonium and selenonium ion with an appended polyhydroxylated side chain. These compounds were designed as transition state mimics of the UGM-catalyzed reaction, where the head groups carrying a permanent positive charge were designed to mimic both the shape and positive charge of the proposed galactopyranosyl cation-like transition state. An HPLC-based UGM inhibition assay indicated that the compounds inhibited about 25% of UGM activity at 500 mu M concentration. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [11] Isopentenyl diphosphate isomerase. Mechanism-based inhibition by diene analogues of isopentenyl diphosphate and dimethylallyl diphosphate
    Wu, Z
    Wouters, J
    Poulter, CD
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (49) : 17433 - 17438
  • [12] ENZYME-ACTIVATED MECHANISM-BASED INHIBITORS
    PALFREYMAN, MG
    BEY, P
    SJOERDSMA, A
    ESSAYS IN BIOCHEMISTRY, 1987, 23 : 28 - 81
  • [13] Mechanism-based inhibitors for the inactivation of the bacterial phosphotriesterase
    Hong, SB
    Mullins, LS
    Shim, HB
    Raushel, FM
    BIOCHEMISTRY, 1997, 36 (29) : 9022 - 9028
  • [14] Mechanism-Based Macrocyclic Inhibitors of Serine Proteases
    Damalanka, Vishnu C.
    Banas, Victoria
    De Bona, Paolo
    Kashipathy, Maithri M.
    Battaile, Kevin
    Lovell, Scott
    Janetka, James W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4833 - 4854
  • [15] DESIGN OF MECHANISM-BASED INHIBITORS OF CHOLESTEROL ESTERASE
    NYANDA, AM
    QUINN, DM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 19 - BIOL
  • [16] Mechanism-based inhibitors of mammalian cholesterol esterase
    Feaster, SR
    Quinn, DM
    LIPASES, PT B: ENZYME CHARACTERIZATION AND UTILIZATION, 1997, 286 : 231 - 252
  • [17] AMINOPROPYLTRANSFERASES - MECHANISTIC STUDIES AND MECHANISM-BASED INHIBITORS
    COWARD, JK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1983, 185 (MAR): : 32 - MEDI
  • [18] Mechanism-based irreversible inhibitors of cytokinin dehydrogenase
    Suttle, JC
    Mornet, R
    JOURNAL OF PLANT PHYSIOLOGY, 2005, 162 (11) : 1189 - 1196
  • [19] NOVEL MECHANISM-BASED INHIBITORS OF Aβ AGGREGATION AND TOXICITY
    Lashuel, Hilal A.
    Eleuteri, Simona
    Di Giovanni, Saviana
    Rockenstein, Edward
    Mante, Mike
    Adame, Antony
    Trejo, Margarita
    Wu, Fang
    Fraering, Patrick C.
    Masliah, Eliezer
    NEUROBIOLOGY OF AGING, 2014, 35 (03) : 720 - 721
  • [20] MECHANISM-BASED INHIBITORS OF ACYL TRANSFER ENZYMES
    KRANTZ, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 195 : 32 - BTEC